Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00004204 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: temozolomide

Sponsor

Herbert Irving Comprehensive Cancer Center